A message from Editor in Chief Marc Garnick, M.D. about treatment
options available to men with androgen-independent prostate
cancer, participating in clinical trials, and previews of other
articles in this issue.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.